US medical device and life sciences giant GE Healthcare Technologies Inc. (NASDAQ: GEHC) released its Q4 and full-year 2024 financial results. The company reported annual revenues of USD19.7 billion, representing a 1% year-on-year (YOY) growth in constant currency terms. Group revenues for Q4 grew by 2% YOY to USD5.3 billion.
Revenue Breakdown
Revenue growth in the US and in Pharmaceutical Diagnostics (PDx) was partially offset by continued market softness in China. For the full year, product sales decreased slightly by 0.3% to USD13.1 billion, while services sales increased by 3% YOY to USD6.6 billion.
Innovation and Partnerships
In 2024, GE Healthcare delivered 40 innovative achievements and established over 50 global partnerships. The company continues to focus on business growth in 2025, having formed long-term collaborations with US-based Sutter Health and UK-based Nuffield Health earlier this year.-Fineline Info & Tech
